{"pageContent": "Purpose: The reporting of quality of life outcomes after prostate cancer treatment has improved with the use of validated instruments and third party data collection, and yet widely disparate continence and potency rates persist among providers. We assessed how well various definitions of these outcomes correspond with each other in the same patients.", "metaData": {"source": "[Erectile dysfunction after nerve-sparing radical prostatectomy]\nhttps://pubmed.ncbi.nlm.nih.gov/29376613/"}}